Injection site reactions are common but generally benign. Learn how to prevent and treat them. Approximately 3 to 5% of patients on tirzepatide develop injection site reactions. Although rarely serious, these reactions can be bothersome and concerning. Here is a practical guide to prevent and treat them. Types of reactions … Read more
Thyroid risk with GLP-1 is a regular concern. Here’s what human versus animal data say. The FDA’s black box warning regarding the risk of C-cell thyroid tumors with GLP-1 agonists has generated understandable concern among patients. This warning is based on animal data. What about… Read more
Gastroparesis is a rare but potentially debilitating side effect of GLP-1 agonists. Here’s how to recognize and prevent it. Gastroparesis, defined by an abnormal slowing of gastric emptying without mechanical obstruction, has received considerable media attention with the rise of GLP-1 treatments. Although rare, this complication can be debilitating and … Read more
The risk of pancreatitis with tirzepatide is real but low. Knowing the warning signs is essential for rapid management. Pancreatitis is the most closely monitored potentially serious side effect in patients on GLP-1 agonists. Although the risk is very low (0.1 to 0.2% in clinical trials), acute pancreatitis … Read more
Hair loss with GLP-1 agonists is a concern for patients. Here’s what science really says about this phenomenon. Hair loss (alopecia) is a growing concern among patients on GLP-1 agonists, amplified by testimonials on social media. But what do scientific data really say? Is it a … Read more
Fatigue with Mounjaro affects approximately 10 to 15% of patients. Discover its causes and how to regain your energy during treatment. Fatigue is an often underestimated side effect of tirzepatide. While rarely mentioned as a reason for discontinuation in clinical studies, it significantly impacts the quality of life of about 10 to 15% … Read more
Nausea is the most common side effect with Mounjaro. Here’s a comprehensive guide to understanding, preventing, and effectively treating it. Between 24% and 33% of patients on tirzepatide experience nausea, primarily at the beginning of treatment and during dose escalations. Although generally transient, this nausea can significantly affect quality of life and lead some patients to discontinue treatment. … Read more
Nausea, fatigue, slow digestion… Mounjaro side effects can be surprising. Discover how to anticipate them, manage them daily, and know when to consult your doctor.